A survey of drug-resistant Mycobacterium tuberculosis and its relationship to HIV infection

AIDS

Volumn 12, Issue 2, 1998, Pages 191-195

  Spellman, Craig W ^a,b   Matty, Keith J ^a   Weis, Stephen E ^a  

^a University of North Texas Health Science Center   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Directly observed therapy; Drug resistance; HIV; Tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; CAPREOMYCIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PATIENT CARE; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; DATA COLLECTION; DRUG RESISTANCE, MICROBIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0032556933     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199802000-00009     Document Type: Article

References (15)

1. Centers for Disease Control: Nosocomial transmission of multidrug-resistant tuberculosis among HIV infected persons: Florida and New York, 1988-1991. MMWR 1991, 40:585-591.
2. Centers for Disease Control: Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system: New York, 1991. MMWR 1992, 41:507-509.
3. Pitchenik AE, Burr J, Miller G, et al.: Outbreaks of drug-resistant tuberculosis at AIDS center. Lancet 1990, 336:440-441.
4. Monno I, Carbonara S, Costa D, et al.: Emergence of drug-resistant Mycobacterium tuberculosis in HIV infected patients [letter]. Lancet 1991, 337:852.
5. Nolan CM, Willaims DL, Cave MD, et al.: Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. Am J Respir Crit Care Med 1995, 152:1067-1071.
6. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW: The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993, 328:521-526.
7. Shafer RW, Chirgwin KD, Glatt AE, Dahdouh MA, Landesman SH, Suster B: HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS. AIDS 1991, 5:399-405.
8. O'Brien RJ: Drug-resistant tuberculosis: etiology, management and prevention. Semin Respir Med 1994, 9:104-112.
9. Bloch AB, Cauthen GM, Onorato IM, et al.: Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994, 271:665-671.
10. Asch A, Knowles L, Rai A, Jones BE, Pogoda J, Barnes PF: Relationship of isoniazid resistance to human immunodeficiency virus infection in patients with tuberculosis. Am J Respir Crit Care Med 1996, 153:1708-1710.
11. Gordin FM, Nelson ET, Matts JP, et al.: The impact of human immunodeficiency virus infection on drug-resistant tuberculosis. Am J Respir Crit Care Med 1996, 154:1478-1483.
12. Brudney K, Dobkin J: Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness and the decline of tuberculosis control programs. Am J Respir Dis 1991, 144:745-749.
13. Reichman LB: The challenge of drug-resistant tuberculosis. Cleve Clin J Med 1994, 61:431-437.
14. Daley CL, Small PM, Schecter GF, et al.: An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N Engl J Med 1992, 326:231-235.
15. Weis SE, Slocum PC, Blais FX, et al.: The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994, 330:1179-1184.